U.S., Jan. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07325227) titled 'Study of Remimazolam for Cataract Surgery' on Dec. 09, 2025.
Brief Summary: The goal of this clinical trial is to learn if the use of the sedative remimazolam improves the safety of patients having cataract surgery by decreasing the number of sedation-related complications during and after surgery, and shortening post-surgical cognitive recovery time.
Study Start Date: Feb. 15
Study Type: INTERVENTIONAL
Condition:
Cataract Surgery Anesthesia
Intervention:
DRUG: Arm 1 Cataract Surgery performed with remimazolam as sedative
Sedation will be remimazolam in one eye and the standard of care in the other eye.
DRUG: Arm 2 Cataract S...